Standout Papers

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric ca... 2009 2026 2014 2020 464
  1. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study (2009)
    Narikazu Boku, Seiichiro Yamamoto et al. The Lancet Oncology

Immediate Impact

74 standout
Sub-graph 1 of 19

Citing Papers

RE.GA.IN.: the Real-world Gastritis Initiative–updating the updates
2024 Standout
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
2023 Standout
7 intermediate papers

Works of Junichiro Nasu being referenced

Usefulness and problems of endoscopic ultrasonography in prediction of the depth of tumor invasion in early gastric cancer.
2011
Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study
2009 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Junichiro Nasu 586 342 301 324 26 768
Mao-Chih Hsieh 441 177 332 210 29 733
Noboru Yamamichi 429 415 291 181 20 712
Hideaki Nishidoi 574 166 370 243 55 710
Pamela Dumas 503 245 254 243 13 670
Toshiyuki Tanahashi 455 212 265 231 50 693
Sooyeon Oh 423 220 412 193 39 750
Rajini Seevaratnam 786 173 415 462 32 953
Arnulf H. H�lscher 443 209 609 197 22 863
Dong‐Seok Han 516 162 359 213 18 694
Alex Geller 321 328 589 234 35 817

All Works

Loading papers...

Rankless by CCL
2026